Trial of Analgesia With Lidocaine or Extended-release Oxycodone for Neuropathic Pain Treatment in Multiple Sclerosis
Status:
Terminated
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
This study will determine whether treatment with an extended-release opioid or topical
lidocaine is effective in relieving distal symmetric lower extremity burning pain associated
with multiple sclerosis (MS). If treatment with topical lidocaine is efficacious, it will
have important implications for understanding this chronic pain syndrome, which is widely
assumed to be caused by central nervous system pathology.